Table 1.

Baseline patient characteristics in Covid-19 patients compared to controls

Characteristic	Covid-19 decedent (N = 10)	Non Covid-19 decedent (N = 20)	P value
Age	63.8 (43-82)	58.6 (34-83)	0.28
GenderMaleFemale	7 (70) 3 (30)	12 (60)8 (40)	0.7
Duration of symptoms (days)	22.2 (5–40)	16.9 (7–58), n = 12	0.34
Duration of hospitalization (days)	16.4 (5–35)	9.1(1–28), n = 18	0.06
Obesity (BMI >30 kg/m^2)	7 (70)	9 (45)	0.26
Hypertension	7 (70)	12 (60)	0.44
Diabetes mellitus	6 (60)	4 (20)	0.11
Hyperlipidemia	5 (50)	9 (45)	1.00
Underlying CHF	4 (40)	3 (15)	0.18
Cardiac arrest (during the last admission)	4 (40)	5 (25)	0.43
Ischemic encephalopathy	0 (0)	1 (5)	1
peripheral circulatory support (ECMO)	0 (0)	0 (0)	1
Intubation	9 (90)	13 (65)	0.2
Mean duration of intubation	11.1 (1–26), n = 9	6.3 (1–26), n = 13	0.051
Mechanical ventilation	9 (90)	13 (65)	0.2
SpO2 (last measured)	80.4 (55–100), n = 10	73.2 (40–100) n = 18	0.37
Renal replacement therapy (dialysis)	5 (50)	6 (30)	0.42
Use of pressors	7 (70)	13 (65)	1
Cases with elevated troponin	3 (30), n = 9	6 (30), n = 15	0.66
Peak troponin (ng/L)a	1.7 (0.02–15.2), n = 9	0.13 (0–0.4), n = 15	0.46
Cases with decreased ejection fraction	2 (20), n = 6	1 (5), n = 16	0.16
Cases with elevated D-dimer	9 (90), n = 9	6 (30), n = 8	0.2
Baseline creatinine (mg/dL)	2.1 (0.78–4.99)	2.4 (0.3–8.2), n = 18	0.72
Immediate cause of death due to bronchopneumonia/ diffuse alveolar damage	7 (70)	14 (70)	1.0
Other immediate causes of death	Sepsis: 2 (20)	Sepsis: 6 (30)
PE: 1 (10)

Data refer to number (percentage) of patients or mean (range).

CHF, congestive heart failure; CAD, coronary artery disease; SpO2, oxygen saturation.

For each characteristic, when information regarding the characteristic was not available for all of the patients in the group, the number of patients is noted as n = x.

^aHighest troponin value available in the last admission.